UnitedHealth Group Incorporated (NYSE:UNH) Holdings Lessened by Stonnington Group LLC

Stonnington Group LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 6.9% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 25,666 shares of the healthcare conglomerate’s stock after selling 1,917 shares during the quarter. UnitedHealth Group makes up 3.5% of Stonnington Group LLC’s holdings, making the stock its 4th biggest holding. Stonnington Group LLC’s holdings in UnitedHealth Group were worth $13,202,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Signature Estate & Investment Advisors LLC increased its holdings in shares of UnitedHealth Group by 1.2% in the 1st quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock valued at $820,000 after purchasing an additional 19 shares in the last quarter. Steph & Co. increased its holdings in UnitedHealth Group by 1.6% during the 1st quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock valued at $658,000 after acquiring an additional 20 shares in the last quarter. First City Capital Management Inc. increased its holdings in UnitedHealth Group by 1.5% during the 1st quarter. First City Capital Management Inc. now owns 1,350 shares of the healthcare conglomerate’s stock valued at $688,000 after acquiring an additional 20 shares in the last quarter. Griffin Asset Management Inc. increased its holdings in UnitedHealth Group by 0.3% during the 1st quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock valued at $3,414,000 after acquiring an additional 21 shares in the last quarter. Finally, Physicians Financial Services Inc. increased its holdings in UnitedHealth Group by 5.2% during the 1st quarter. Physicians Financial Services Inc. now owns 424 shares of the healthcare conglomerate’s stock valued at $216,000 after acquiring an additional 21 shares in the last quarter. 87.25% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have weighed in on UNH shares. Argus raised their target price on shares of UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a report on Monday, July 25th. Sanford C. Bernstein cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target on the stock. in a research note on Thursday, May 26th. They noted that the move was a valuation call. BMO Capital Markets raised their price target on shares of UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. UBS Group raised their price target on shares of UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research note on Thursday, July 21st. Finally, Mizuho raised their price target on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, August 10th. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $585.65.

Insider Activity

In related news, Director Stephen J. Hemsley sold 99,312 shares of UnitedHealth Group stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total value of $53,059,422.24. Following the completion of the sale, the director now owns 787,372 shares in the company, valued at $420,669,238.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the transaction, the director now owns 787,372 shares of the company’s stock, valued at $420,669,238.44. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the transaction, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at approximately $18,866,882.82. The disclosure for this sale can be found here. Insiders have sold 140,324 shares of company stock worth $75,086,185 over the last 90 days. Company insiders own 0.40% of the company’s stock.

UnitedHealth Group Trading Down 0.4 %

Shares of UNH stock opened at $521.02 on Monday. The stock has a market cap of $487.35 billion, a price-to-earnings ratio of 27.21, a price-to-earnings-growth ratio of 1.63 and a beta of 0.76. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The firm’s 50 day moving average price is $529.29 and its two-hundred day moving average price is $511.81.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The firm had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. UnitedHealth Group’s revenue was up 12.6% compared to the same quarter last year. During the same period in the previous year, the company posted $4.70 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th will be paid a dividend of $1.65 per share. The ex-dividend date of this dividend is Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.27%. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.